Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Maneesh K. Arora | M | 55 |
Elephas Biosciences Corp.
Elephas Biosciences Corp. Medical/Nursing ServicesHealth Services Elephas Biosciences Corp. is a live tumor imaging company that provides cancer diagnostic solutions to predict treatment outcomes and accelerate drug development. The company is based in Madison, WI and was founded by Maneesh K. Arora, who has been the CEO since incorporation. The company's revolutionary diagnostic platform brings insights to cancer treatment decisions and accelerates immuno-oncology drug development. Investors can learn about clinical trials aimed at predicting responses to immunotherapy and how immunotherapeutic drug development can be accelerated with Elephas Biosciences's cybrid. | - |
Steven Galson | M | 67 |
Elephas Biosciences Corp.
Elephas Biosciences Corp. Medical/Nursing ServicesHealth Services Elephas Biosciences Corp. is a live tumor imaging company that provides cancer diagnostic solutions to predict treatment outcomes and accelerate drug development. The company is based in Madison, WI and was founded by Maneesh K. Arora, who has been the CEO since incorporation. The company's revolutionary diagnostic platform brings insights to cancer treatment decisions and accelerates immuno-oncology drug development. Investors can learn about clinical trials aimed at predicting responses to immunotherapy and how immunotherapeutic drug development can be accelerated with Elephas Biosciences's cybrid. | 2 jaar |
Paul Berns | M | 57 |
Elephas Biosciences Corp.
Elephas Biosciences Corp. Medical/Nursing ServicesHealth Services Elephas Biosciences Corp. is a live tumor imaging company that provides cancer diagnostic solutions to predict treatment outcomes and accelerate drug development. The company is based in Madison, WI and was founded by Maneesh K. Arora, who has been the CEO since incorporation. The company's revolutionary diagnostic platform brings insights to cancer treatment decisions and accelerates immuno-oncology drug development. Investors can learn about clinical trials aimed at predicting responses to immunotherapy and how immunotherapeutic drug development can be accelerated with Elephas Biosciences's cybrid. | 2 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 3 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Michell B. Arora
- Persoonlijk netwerk